Trial site
Indago Research & Health Center, Inc
- 9running trials
- 21closed trials
The trials here
What the 30 trials at this site are about, from their registry records.
- Conditions
- Obesity10 trials
- Type 2 diabetes8 trials
- Alzheimer disease7 trials
- Mild cognitive impairment3 trials
- Chronic kidney disease1 trial
- Heart failure1 trial
- High blood pressure1 trial
- Type 1 diabetes1 trial
- Phase
- Phase 314 trials
- Phase 212 trials
- Phase 1/23 trials
- Status
- Completed19 trials
- Active, not recruiting8 trials
- Terminated2 trials
- Recruiting1 trial
- Lead sponsor
- Eli Lilly and Company13 trials
- BioNTech SE4 trials
- Novo Nordisk A/S4 trials
- Pfizer4 trials
- Mineralys Therapeutics Inc.1 trial
- and 4 more
Running trials
Recruiting
A Study to Learn About mRNA Vaccines Against Influenza in Adults
Active, not recruiting
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)
Active, not recruiting
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Active, not recruiting
A Study of Health Care Use and Costs in Participants With Early Stage Alzheimer's Disease (AD)
Active, not recruiting
Closed trials
Terminated
A Study of LY3549492 in Adults With Obesity or Overweight With Type 2 Diabetes
Completed
A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People
Completed
Completed
A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People
Completed
Completed
Completed
A Study About Modified RNA Vaccines Against Influenza in Healthy Adults
Completed
A Study to Learn About a Combined COVID-19 and Influenza Shot in Healthy Adults
Completed
Completed
Completed
Completed
A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease
Completed
Completed
Completed
Safety and Efficacy of Bimagrumab and Semaglutide in Adults Who Are Overweight or Obese
Completed
Completed
Completed
Completed
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)
Completed
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)
Terminated
Site data: ClinicalTrials.govUpdated 18 Nov 2026